# Registry of Patients Having Received oNKord®

> **NCT05290662** · — · RECRUITING · sponsor: **Glycostem Therapeutics BV** · enrollment: 50 (estimated)

## Conditions studied

- AML

## Interventions

- **DRUG:** oNKord®
- **DRUG:** Cyclophosphamide/Fludarabine (Cy/Flu)

## Key facts

- **NCT ID:** NCT05290662
- **Lead sponsor:** Glycostem Therapeutics BV
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2022-06-14
- **Primary completion:** 2028-03
- **Final completion:** 2028-03
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2022-08-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05290662

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05290662, "Registry of Patients Having Received oNKord®". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT05290662. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*